Global Pneumococcal Conjugate Vaccine (PCV) Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size 2017-2028

2.1.2 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Pneumococcal Conjugate Vaccine (PCV) Segment by Type

2.2.1 23-valent Vaccine

2.2.2 10-valent Vaccine

2.2.3 7-valent Vaccine

2.2.4 13-valent Vaccine

2.3 Pneumococcal Conjugate Vaccine (PCV) Market Size by Type

2.3.1 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2017-2022)

2.4 Pneumococcal Conjugate Vaccine (PCV) Segment by Application

2.4.1 Child

2.4.2 Adult

2.5 Pneumococcal Conjugate Vaccine (PCV) Market Size by Application

2.5.1 Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2017-2022)

3 Pneumococcal Conjugate Vaccine (PCV) Market Size by Player

3.1 Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Players

3.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2020-2022)

3.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Players (2020-2022)

3.2 Global Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Pneumococcal Conjugate Vaccine (PCV) by Regions

4.1 Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions (2017-2022)

4.2 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2017-2022)

4.3 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2017-2022)

4.4 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2017-2022)

4.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Growth (2017-2022)

5 Americas

5.1 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2017-2022)

5.2 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022)

5.3 Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2017-2022)

6.2 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022)

6.3 APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Pneumococcal Conjugate Vaccine (PCV) by Country (2017-2022)

7.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022)

7.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) by Region (2017-2022)

8.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022)

8.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.1 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Regions (2023-2028)

10.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Regions (2023-2028)

10.1.2 Americas Pneumococcal Conjugate Vaccine (PCV) Forecast

10.1.3 APAC Pneumococcal Conjugate Vaccine (PCV) Forecast

10.1.4 Europe Pneumococcal Conjugate Vaccine (PCV) Forecast

10.1.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Forecast

10.2 Americas Pneumococcal Conjugate Vaccine (PCV) Forecast by Country (2023-2028)

10.2.1 United States Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.2.2 Canada Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.2.3 Mexico Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.2.4 Brazil Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.3 APAC Pneumococcal Conjugate Vaccine (PCV) Forecast by Region (2023-2028)

10.3.1 China Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.3.2 Japan Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.3.3 Korea Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.3.4 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.3.5 India Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.3.6 Australia Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.4 Europe Pneumococcal Conjugate Vaccine (PCV) Forecast by Country (2023-2028)

10.4.1 Germany Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.4.2 France Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.4.3 UK Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.4.4 Italy Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.4.5 Russia Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.5 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Forecast by Region (2023-2028)

10.5.1 Egypt Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.5.2 South Africa Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.5.3 Israel Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.5.4 Turkey Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.5.5 GCC Countries Pneumococcal Conjugate Vaccine (PCV) Market Forecast

10.6 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Type (2023-2028)

10.7 Global Pneumococcal Conjugate Vaccine (PCV) Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Offered

11.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Pfizer Main Business Overview

11.1.5 Pfizer Latest Developments

11.2 GSK

11.2.1 GSK Company Information

11.2.2 GSK Pneumococcal Conjugate Vaccine (PCV) Product Offered

11.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 GSK Main Business Overview

11.2.5 GSK Latest Developments

11.3 Sanofi

11.3.1 Sanofi Company Information

11.3.2 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Offered

11.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Sanofi Main Business Overview

11.3.5 Sanofi Latest Developments

11.4 Merck

11.4.1 Merck Company Information

11.4.2 Merck Pneumococcal Conjugate Vaccine (PCV) Product Offered

11.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Merck Main Business Overview

11.4.5 Merck Latest Developments

11.5 Walvax Biotechnology

11.5.1 Walvax Biotechnology Company Information

11.5.2 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Offered

11.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Walvax Biotechnology Main Business Overview

11.5.5 Walvax Biotechnology Latest Developments

11.6 Royal (Wuxi) Bio-Pharmaceutical

11.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information

11.6.2 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Offered

11.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Royal (Wuxi) Bio-Pharmaceutical Main Business Overview

11.6.5 Royal (Wuxi) Bio-Pharmaceutical Latest Developments

11.7 Zhifei Biologic

11.7.1 Zhifei Biologic Company Information

11.7.2 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Offered

11.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Zhifei Biologic Main Business Overview

11.7.5 Zhifei Biologic Latest Developments

11.8 Serum Institute of India

11.8.1 Serum Institute of India Company Information

11.8.2 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Offered

11.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Serum Institute of India Main Business Overview

11.8.5 Serum Institute of India Latest Developments

12 Research Findings and Conclusion

Table 1. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of 23-valent Vaccine

Table 3. Major Players of 10-valent Vaccine

Table 4. Major Players of 7-valent Vaccine

Table 5. Major Players of 13-valent Vaccine

Table 6. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2017-2022)

Table 9. Pneumococcal Conjugate Vaccine (PCV) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2017-2022)

Table 12. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Player (2020-2022)

Table 14. Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Products Offered

Table 15. Pneumococcal Conjugate Vaccine (PCV) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Regions (2017-2022)

Table 20. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country (2017-2022)

Table 22. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2017-2022)

Table 24. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2017-2022)

Table 26. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2017-2022)

Table 28. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2017-2022)

Table 30. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2017-2022)

Table 32. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country (2017-2022)

Table 34. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2017-2022)

Table 36. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Pneumococcal Conjugate Vaccine (PCV)

Table 45. Key Market Challenges & Risks of Pneumococcal Conjugate Vaccine (PCV)

Table 46. Key Industry Trends of Pneumococcal Conjugate Vaccine (PCV)

Table 47. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share Forecast by Application (2023-2028)

Table 53. Pfizer Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors

Table 54. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Offered

Table 55. Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Pfizer Main Business

Table 57. Pfizer Latest Developments

Table 58. GSK Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors

Table 59. GSK Pneumococcal Conjugate Vaccine (PCV) Product Offered

Table 60. GSK Main Business

Table 61. GSK Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. GSK Latest Developments

Table 63. Sanofi Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors

Table 64. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Offered

Table 65. Sanofi Main Business

Table 66. Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Sanofi Latest Developments

Table 68. Merck Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors

Table 69. Merck Pneumococcal Conjugate Vaccine (PCV) Product Offered

Table 70. Merck Main Business

Table 71. Merck Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Merck Latest Developments

Table 73. Walvax Biotechnology Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors

Table 74. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Offered

Table 75. Walvax Biotechnology Main Business

Table 76. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Walvax Biotechnology Latest Developments

Table 78. Royal (Wuxi) Bio-Pharmaceutical Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors

Table 79. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Offered

Table 80. Royal (Wuxi) Bio-Pharmaceutical Main Business

Table 81. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Royal (Wuxi) Bio-Pharmaceutical Latest Developments

Table 83. Zhifei Biologic Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors

Table 84. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Offered

Table 85. Zhifei Biologic Main Business

Table 86. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Zhifei Biologic Latest Developments

Table 88. Serum Institute of India Details, Company Type, Pneumococcal Conjugate Vaccine (PCV) Area Served and Its Competitors

Table 89. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Offered

Table 90. Serum Institute of India Main Business

Table 91. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Serum Institute of India Latest Developments

List of Figures

Figure 1. Pneumococcal Conjugate Vaccine (PCV) Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type in 2021

Figure 7. Pneumococcal Conjugate Vaccine (PCV) in Child

Figure 8. Global Pneumococcal Conjugate Vaccine (PCV) Market: Child (2017-2022) & ($ Millions)

Figure 9. Pneumococcal Conjugate Vaccine (PCV) in Adult

Figure 10. Global Pneumococcal Conjugate Vaccine (PCV) Market: Adult (2017-2022) & ($ Millions)

Figure 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2021

Figure 12. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Player in 2021

Figure 13. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size 2017-2022 ($ Millions)

Figure 15. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size 2017-2022 ($ Millions)

Figure 16. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2017-2022 ($ Millions)

Figure 18. Americas Pneumococcal Conjugate Vaccine (PCV) Value Market Share by Country in 2021

Figure 19. Americas Pneumococcal Conjugate Vaccine (PCV) Consumption Market Share by Type in 2021

Figure 20. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2021

Figure 21. United States Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region in 2021

Figure 26. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2021

Figure 27. China Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Country in 2021

Figure 34. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type in 2021

Figure 35. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2021

Figure 36. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Application in 2021

Figure 44. Egypt Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Pneumococcal Conjugate Vaccine (PCV) Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 50. APAC Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 51. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 53. United States Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 54. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 57. China Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 58. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 59. Korea Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 61. India Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 62. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 63. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 64. France Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 65. UK Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 66. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 67. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 68. Spain Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 71. Israel Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Pneumococcal Conjugate Vaccine (PCV) Market Size 2023-2028 ($ Millions)